WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (NASDAQ:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced that the Company will report its financial results for the first quarter of 2008 after the U.S. Financial Markets close on Thursday, April 24, 2008. Following the announcement, Panacos will hold a conference call to discuss the results. Alan W. Dunton, M.D., President and Chief Executive Officer, will host the call.
